Germain, Dominique P
Charrow, Joel
Desnick, Robert J
Guffon, Nathalie
Kempf, Judy
Lachmann, Robin H
Lemay, Roberta
Linthorst, Gabor E
Packman, Seymour
Scott, C Ronald
Waldek, Stephen
Warnock, David G
Weinreb, Neal J
Wilcox, William R
Clinical trials referenced in this document:
Documents that mention this clinical trial
Ten-year outcome of enzyme replacement therapy with agalsidase beta in patients with Fabry disease
https://doi.org/10.1136/jmedgenet-2014-102797
Documents that mention this clinical trial
Antiproteinuric therapy and Fabry nephropathy: factors associated with preserved kidney function during agalsidase-beta therapy
https://doi.org/10.1136/jmedgenet-2015-103471
Ten-year outcome of enzyme replacement therapy with agalsidase beta in patients with Fabry disease
https://doi.org/10.1136/jmedgenet-2014-102797
Time to treatment benefit for adult patients with Fabry disease receiving agalsidase β: data from the Fabry Registry
https://doi.org/10.1136/jmedgenet-2015-103486
Use of a rare disease registry for establishing phenotypic classification of previously unassigned <i>GLA</i> variants: a consensus classification system by a multispecialty Fabry disease genotype–phenotype workgroup
https://doi.org/10.1136/jmedgenet-2019-106467
Documents that mention this clinical trial
Ten-year outcome of enzyme replacement therapy with agalsidase beta in patients with Fabry disease
https://doi.org/10.1136/jmedgenet-2014-102797
Documents that mention this clinical trial
Antiproteinuric therapy and Fabry nephropathy: factors associated with preserved kidney function during agalsidase-beta therapy
https://doi.org/10.1136/jmedgenet-2015-103471
Ten-year outcome of enzyme replacement therapy with agalsidase beta in patients with Fabry disease
https://doi.org/10.1136/jmedgenet-2014-102797
Time to treatment benefit for adult patients with Fabry disease receiving agalsidase β: data from the Fabry Registry
https://doi.org/10.1136/jmedgenet-2015-103486
Use of a rare disease registry for establishing phenotypic classification of previously unassigned <i>GLA</i> variants: a consensus classification system by a multispecialty Fabry disease genotype–phenotype workgroup
https://doi.org/10.1136/jmedgenet-2019-106467